/NOT FOR DISTRIBUTION TO US WIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES OF
AMERICA./
HALIFAX, Nov. 21, 2016 /CNW/ - Nova Leap Health Corp.
(TSXV:NLH) ("Nova Leap" or the "Company") is pleased to announce
that it has undertaken a non-brokered private placement financing
to raise up to $2,000,000 by the sale
of units of the Company at a price of $0.20 per unit.
Each unit is comprised of one common share of the Company and a
one-half common share purchase warrant. Two half-warrants
entitle the holder to acquire one common share of the Company for
$0.35 for a period of 24 months from
the closing date of this private placement. The private
placement is anticipated to close on or before December 22, 2016. The common shares and
warrants are subject to a 4 month hold period. Insiders of
Nova Leap may participate in the
private placement.
In connection with the offering, a finder's fee may be paid
consisting of a cash payment equal to up to 6% of the proceeds
raised from this private placement and that number of
non-transferable finder's fee warrants as is equal to up to 6% of
the number of common shares issued pursuant to this private
placement at closing. Each finder's fee warrant will be
exercisable into one common share of the Company at $0.35 per share for a period of 24 months from
the closing date.
The proceeds from the private placement will be used for general
working capital purposes. The private placement is subject to TSX
Venture Exchange and other required regulatory approval.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Nova Leap Health Corp.